Interní Med. 2003; 5(9): 437-446

Farmakoterapie arytmií

doc. MUDr. Miloslav Pleskot CSc, MUDr. Jaroslav Kajzr, MUDr. Radka Hazuková
I. interní klinika Fakultní nemocnice v Hradci Králové

Keywords: antiarrhythmics, amiodarone, arrhythmias, betablockers, pharmacotherapy.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pleskot M, Kajzr J, Hazuková R. Farmakoterapie arytmií. Interní Med. 2003;5(9):437-446.

Antiarytmika dělíme podle jejich vlivu na membránový akční potenciál a na mechanizmy vzniku arytmií. Cílem léčby je odstranění symptomů, úprava hemodynamické závažnosti a ovlivnění prognózy. Okamžitý léčebný účinek a prognostický význam u nemocných s maligními komorovými tachyarytmiemi a po srdečním infarktu mají betablokátory a v některých případech amiodaron.

PHARMACOTHERAPY OF ARRHYTHMIAS

We divide antiarrhythmic medication according to their influence on membraned action potential and on mechnisms of development of arrhythmias. The aim of therapy is relieving symptoms, managing haemodynamic complications and influencing prognosis. Betablockers and in some cases amiodarone, have immediate therapeutic effects and prognostic value in patients with malignant ventricular arrhythmias and after myocardial infarction.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amiodarone Trials Meta-Analysis (ATMA) investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: metaanalysis of individual data from 6 500 patients in randomised trials. Lancet 1997; 350: 1417-1424.
    2. Beta-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results. JAMA 1982; 247: 1707-1714. Go to original source... Go to PubMed...
    3. Boissel JP, Leizorovicz A, Picolet H, Peyrieux JC for the APSI Investigators. Secondary prevention after high risk acute myocardial infarction with low-dose acebutolol. Amer J Cardiol 1990; 66: 251-260. Go to original source... Go to PubMed...
    4. Boriani G, Biffi M, Capucci A, Botto G, Broffoni T, Ongari M, et al. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. PACE 1998; 21: 2470-2474. Go to original source... Go to PubMed...
    5. Cairns JA, Connolly S, Roberts R, Gent M. Randomized trial of outcome after myocardial infarction in patients with frequent of repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-682. Go to original source... Go to PubMed...
    6. Coplen SE, Antman EM, Berlin JA, Hewit TP, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 1990; 82: 1106-1116. Go to original source... Go to PubMed...
    7. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R for GESICA. Randomized trial of low dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-498. Go to original source... Go to PubMed...
    8. Harrison DC. Antiarrhythmic drug classification: New science and practical applications. Am J Cardiol 1985; 56: 185-187. Go to original source... Go to PubMed...
    9. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ. Randomized trial of effect of amiodarone on mortality in patients with left - ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667-674. Go to original source... Go to PubMed...
    10. Kowey PR. Pharmacological effects of antiarrhythmic drugs. Arch Intern Med 1998; 158: 325-332. Go to original source... Go to PubMed...
    11. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754. Go to original source... Go to PubMed...
    12. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New Engl J Med 1996; 335: 1933-1940. Go to original source... Go to PubMed...
    13. Stroobandt R, Stiels B, Hoebrecht R. Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol 1997; 79: 418-423. Go to original source... Go to PubMed...
    14. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84: 1831-1851. Go to original source... Go to PubMed...
    15. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppresion after myocardial infarction. N Engl J Med 1989; 321: 406-412. Go to original source... Go to PubMed...
    16. The Danish Study Group pn Verapamil in Myocardial Infarction. Effect on verapamil on mortality on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Amer J Cardiol 1990; 66: 779-785. Go to original source... Go to PubMed...
    17. Vaughan Williams EM. A classification of arrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984; 24: 129-147. Go to original source... Go to PubMed...
    18. Waldo A, Camm A, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7-12. Go to original source... Go to PubMed...
    19. Widimský J. Nežádoucí účinky amiodaronu. Cor Vasa 2000; 42: 235-242.
    20. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction - Lessons from overviews of recent randomized controlled trials. Circulation 1990; 82 (Suppl. II): 117-134.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.